Ann Marie Hake

13.1k total citations
68 papers, 2.3k citations indexed

About

Ann Marie Hake is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Ann Marie Hake has authored 68 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 24 papers in Physiology and 10 papers in Pharmacology. Recurrent topics in Ann Marie Hake's work include Dementia and Cognitive Impairment Research (28 papers), Alzheimer's disease research and treatments (18 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ann Marie Hake is often cited by papers focused on Dementia and Cognitive Impairment Research (28 papers), Alzheimer's disease research and treatments (18 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ann Marie Hake collaborates with scholars based in United States, China and Nigeria. Ann Marie Hake's co-authors include Martin R. Farlow, Frederick W. Unverzagt, Sujuan Gao, Jill R. Murrell, Hugh C. Hendrie, Kathleen Hall, Rodger J. Elble, P. F. Reyes, Carol McCleary and Annlia Paganini‐Hill and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Ann Marie Hake

67 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Marie Hake United States 27 835 738 287 284 282 68 2.3k
Roger Clarnette Australia 24 767 0.9× 682 0.9× 161 0.6× 347 1.2× 236 0.8× 48 2.0k
Olivier Rouaud France 33 1.2k 1.4× 794 1.1× 199 0.7× 367 1.3× 360 1.3× 119 4.2k
Anna‐Maija Tolppanen Finland 34 1.3k 1.6× 845 1.1× 262 0.9× 229 0.8× 305 1.1× 172 3.7k
Richard Isaacson United States 25 711 0.9× 1.1k 1.4× 325 1.1× 430 1.5× 433 1.5× 68 2.8k
David Bachman United States 29 1.3k 1.5× 993 1.3× 185 0.6× 123 0.4× 349 1.2× 68 3.4k
Ya‐Nan Ou China 25 835 1.0× 826 1.1× 170 0.6× 174 0.6× 328 1.2× 104 2.6k
Janice E. Knoefel United States 23 1.1k 1.4× 767 1.0× 133 0.5× 131 0.5× 235 0.8× 43 2.6k
Rita Peila United States 21 1.0k 1.3× 1.4k 1.9× 284 1.0× 515 1.8× 526 1.9× 55 3.3k
Asenath La Rue United States 30 1.5k 1.8× 1.2k 1.6× 118 0.4× 207 0.7× 292 1.0× 68 3.1k
Lena Kilander Sweden 25 496 0.6× 868 1.2× 171 0.6× 98 0.3× 437 1.5× 42 1.9k

Countries citing papers authored by Ann Marie Hake

Since Specialization
Citations

This map shows the geographic impact of Ann Marie Hake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Marie Hake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Marie Hake more than expected).

Fields of papers citing papers by Ann Marie Hake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Marie Hake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Marie Hake. The network helps show where Ann Marie Hake may publish in the future.

Co-authorship network of co-authors of Ann Marie Hake

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Marie Hake. A scholar is included among the top collaborators of Ann Marie Hake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Marie Hake. Ann Marie Hake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Liqin, Xiaohong He, Yegang Du, et al.. (2022). Blood Selenium and Serum Glutathione Peroxidase Levels Were Associated with Serum β-Amyloid in Older Adults. Biological Trace Element Research. 201(8). 3679–3687. 8 indexed citations
2.
Vargas, Bert B., Delphine Magis, Erin Doty, et al.. (2020). Assessment to Identify Predictors of 2-Hour Pain Freedom among Patients Enrolled in 2 Phase 3 Studies of Lasmiditan for Acute Treatment of Migraine (1763). Neurology. 94(15_supplement). 1 indexed citations
3.
Smith, Timothy R., John H. Krege, Suchitrita S. Rathmann, et al.. (2020). Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies. Neurology and Therapy. 9(2). 459–471. 9 indexed citations
4.
Johns, Brendan T., Vanessa Taler, David B. Pisoni, et al.. (2017). Cognitive modeling as an interface between brain and behavior: Measuring the semantic decline in mild cognitive impairment.. Canadian Journal of Experimental Psychology/Revue canadienne de psychologie expérimentale. 72(2). 117–126. 17 indexed citations
5.
Unverzagt, Frederick W., Ann Marie Hake, Ran Liao, et al.. (2016). Nail Selenium Level and Diabetes in Older People in Rural China.. PubMed. 29(11). 818–824. 15 indexed citations
6.
Lebrec, Jérémie, Haya Ascher‐Svanum, Yunfei Chen, et al.. (2016). Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease. BMC Geriatrics. 16(1). 93–93. 23 indexed citations
7.
Hendrie, Hugh C., Ann Marie Hake, Kathleen A. Lane, et al.. (2015). Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. PMC. 5 indexed citations
8.
Su, Liqin, Sujuan Gao, Frederick W. Unverzagt, et al.. (2015). Selenium Level and Dyslipidemia in Rural Elderly Chinese. PMC. 3 indexed citations
9.
Henley, David, Sherie A. Dowsett, Yunfei Chen, et al.. (2015). Alzheimer’s disease progression by geographical region in a clinical trial setting. Alzheimer s Research & Therapy. 7(1). 43–43. 23 indexed citations
10.
Su, Liqin, Sujuan Gao, Frederick W. Unverzagt, et al.. (2015). Selenium Level and Dyslipidemia in Rural Elderly Chinese. PLoS ONE. 10(9). e0136706–e0136706. 31 indexed citations
11.
Gao, Sujuan, Frederick W. Unverzagt, Kathleen Hall, et al.. (2014). Mild Cognitive Impairment, Incidence, Progression, and Reversion: Findings from a Community-based Cohort of Elderly African Americans. PMC. 2 indexed citations
12.
Cheng, Yibin, Yinlong Jin, Frederick W. Unverzagt, et al.. (2014). The relationship between cholesterol and cognitive function is homocysteine-dependent. SHILAP Revista de lepidopterología. 10 indexed citations
13.
Gao, Sujuan, Yibin Cheng, Frederick W. Unverzagt, et al.. (2014). The relationship between cholesterol and cognitive function is homocysteine-dependent. Clinical Interventions in Aging. 9. 1823–1823. 31 indexed citations
14.
Hendrie, Hugh C., Olusegun Baiyewu, Kathleen A. Lane, et al.. (2013). Homocysteine levels and dementia risk in Yoruba and African Americans. International Psychogeriatrics. 25(11). 1859–1866. 7 indexed citations
15.
Unverzagt, Frederick W., Adesola Ogunniyi, Vanessa Taler, et al.. (2010). Incidence and Risk Factors for Cognitive Impairment No Dementia and Mild Cognitive Impairment in African Americans. Alzheimer Disease & Associated Disorders. 25(1). 4–10. 29 indexed citations
16.
Ghetti, Bernardino, Ann Marie Hake, Jill R. Murrell, et al.. (2008). P3‐221: Familial Alzheimer's disease associated with the V717L amyloid precursor protein gene mutation: Neuropathological characterization. Alzheimer s & Dementia. 4(4S_Part_18). 3 indexed citations
17.
Edwards, Keith R., Donald R. Royall, Linda A. Hershey, et al.. (2007). Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study. Dementia and Geriatric Cognitive Disorders. 23(6). 401–405. 64 indexed citations
18.
Blekher, Tanya, Robert D. Yee, Ann Marie Hake, et al.. (2004). Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. Vision Research. 44(23). 2729–2736. 64 indexed citations
19.
O’Donnell, Brian F., et al.. (2003). Visual function in Huntington's disease patients and presymptomatic gene carriers. Movement Disorders. 18(9). 1027–1034. 11 indexed citations
20.
Murrell, Jill R., Ann Marie Hake, Kimberly A. Quaid, Martin R. Farlow, & Bernardino Ghetti. (2000). Early-Onset Alzheimer Disease Caused by a New Mutation (V717L) in the Amyloid Precursor Protein Gene. Archives of Neurology. 57(6). 885–885. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Clarnette Breakdown of academic impact, for papers by Olivier Rouaud Breakdown of academic impact, for papers by Anna‐Maija Tolppanen Breakdown of academic impact, for papers by Richard Isaacson Breakdown of academic impact, for papers by David Bachman Breakdown of academic impact, for papers by Ya‐Nan Ou Breakdown of academic impact, for papers by Janice E. Knoefel Breakdown of academic impact, for papers by Rita Peila Breakdown of academic impact, for papers by Asenath La Rue Breakdown of academic impact, for papers by Lena Kilander
Rankless by CCL
2026